Based on this, and the lack of literature pertaining to circulating endothelial-damage-related molecules in this context, we sought to determine if E-selectin, ICAM-1, and ET-1 could be useful as screening biomarkers for the detection of AD-ILD+. This evidence concerns the gene ICAM1 and Alzheimer disease.